Palladino Francesco, Canadè Adolfo, Bianchi Annamaria, Lesti Giulio, Antoniol Onorima Monica, Macis Giuseppe, Marano Pasquale
Istituto di Radiologia, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Roma, Italy.
Rays. 2003 Jan-Mar;28(1):45-61.
Molecular imaging includes all imaging methods applied in the identification, characterization and assessment "in vivo" of biological processes which occur at the cellular and molecular level. Molecular imaging parallels the remarkable advances achieved in the medical field, culminated in the sequencing of human DNA, the genome project. The understanding of the genetic basis of diseases and of human biology in general, together with the development of new drugs, led to a growing need for novel, sensitive and safe imaging technology to be rapidly translated from animal models into patients. The present evaluation of presence/absence of disease is based on anatomic and morphologic changes, the result of underlying molecular alterations. Direct "in vivo" visualization of these alterations allows early diagnosis before the onset of typical pathologic manifestations. Similarly, short-term effects of therapy can be directly visualized. In a near future, "evidence-based" medicine will become "presymptomatic" medicine. Histopathology will be replaced by "molecular pathology" with genomic implications in disease classification. In the near future the conventional morphologic methods should be supported and then replaced by the new functional and molecular methods with additional information proved useful for the diagnostic approach. In this article, the potentialities and applications of Nuclear Medicine, Magnetic Resonance Imaging, Optical Imaging and Contrast-enhanced Ultrasound are reviewed.
分子成像包括所有用于在细胞和分子水平上对生物过程进行“体内”识别、表征和评估的成像方法。分子成像与医学领域取得的显著进展同步,最终促成了人类DNA测序,即基因组计划。对疾病的遗传基础以及一般人类生物学的理解,再加上新药的研发,使得人们越来越需要将新颖、灵敏且安全的成像技术迅速从动物模型应用于患者。目前对疾病存在与否的评估基于解剖学和形态学变化,而这些变化是潜在分子改变的结果。对这些改变进行直接的“体内”可视化能够在典型病理表现出现之前实现早期诊断。同样,治疗的短期效果也能够直接可视化。在不久的将来,“循证”医学将变为“症状前”医学。组织病理学将被具有疾病分类基因组学意义的“分子病理学”所取代。在不久的将来,传统形态学方法应得到支持,然后被新的功能和分子方法所取代,这些新方法提供的额外信息已被证明对诊断方法有用。本文将对核医学、磁共振成像、光学成像和超声造影的潜力及应用进行综述。